303 related articles for article (PubMed ID: 18220755)
1. Role of lysophosphatidylcholine (LPC) in atherosclerosis.
Matsumoto T; Kobayashi T; Kamata K
Curr Med Chem; 2007; 14(30):3209-20. PubMed ID: 18220755
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and atherogenic disease association of lysophosphatidylcholine.
Schmitz G; Ruebsaamen K
Atherosclerosis; 2010 Jan; 208(1):10-8. PubMed ID: 19570538
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis.
Kougias P; Chai H; Lin PH; Lumsden AB; Yao Q; Chen C
Med Sci Monit; 2006 Jan; 12(1):RA5-16. PubMed ID: 16369478
[TBL] [Abstract][Full Text] [Related]
4. Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation.
Fujita Y; Yoshizumi M; Izawa Y; Ali N; Ohnishi H; Kanematsu Y; Ishizawa K; Tsuchiya K; Tamaki T
Endocrinology; 2006 Mar; 147(3):1377-85. PubMed ID: 16322069
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine: Potential Target for the Treatment of Chronic Pain.
Ren J; Lin J; Yu L; Yan M
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955410
[TBL] [Abstract][Full Text] [Related]
6. The atherogenic actions of LPC on vascular smooth muscle cells and its LPA receptor mediated mechanism.
Bao L; Qi J; Wang YW; Xi Q; Tserennadmid T; Zhao PF; Qi J; Damirin A
Biochem Biophys Res Commun; 2018 Sep; 503(3):1911-1918. PubMed ID: 30064908
[TBL] [Abstract][Full Text] [Related]
7. Effects of atrial and brain natriuretic peptides on lysophosphatidylcholine-mediated endothelial dysfunction.
Murohara T; Kugiyama K; Ota Y; Doi H; Ogata N; Ohgushi M; Yasue H
J Cardiovasc Pharmacol; 1999 Dec; 34(6):870-8. PubMed ID: 10598132
[TBL] [Abstract][Full Text] [Related]
8. Endothelins specifically recognize lysophosphatidylcholine micelles.
Sato A; Ebina K
J Pept Sci; 2013 Jun; 19(6):355-61. PubMed ID: 23576491
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells.
Flavahan NA
Am J Physiol; 1993 Mar; 264(3 Pt 2):H722-7. PubMed ID: 8456975
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Cardiovasc Pharmacol; 2002 Mar; 39(3):449-59. PubMed ID: 11862125
[TBL] [Abstract][Full Text] [Related]
11. The mechanisms of lysophosphatidylcholine in the development of diseases.
Liu P; Zhu W; Chen C; Yan B; Zhu L; Chen X; Peng C
Life Sci; 2020 Apr; 247():117443. PubMed ID: 32084434
[TBL] [Abstract][Full Text] [Related]
12. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation.
Murohara T; Kugiyama K; Ohgushi M; Sugiyama S; Ohta Y; Yasue H
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2441-9. PubMed ID: 7810742
[TBL] [Abstract][Full Text] [Related]
13. Fatty acyl composition of lysophosphatidylcholine is important in atherosclerosis.
Akerele OA; Cheema SK
Med Hypotheses; 2015 Dec; 85(6):754-60. PubMed ID: 26604024
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidylcholine promotes SREBP-2 activation via rapid cholesterol efflux and SREBP-2-independent cytokine release in human endothelial cells.
Morita M; Sekine A; Urano Y; Nishimura T; Takabe W; Arai H; Hamakubo T; Kodama T; Noguchi N
J Biochem; 2015 Oct; 158(4):331-8. PubMed ID: 25998247
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2.
Millanvoye-Van Brussel E; Topal G; Brunet A; Do Pham T; Deckert V; Rendu F; David-Dufilho M
Biochem J; 2004 Jun; 380(Pt 2):533-9. PubMed ID: 14992685
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidylcholine-induced cytotoxicity and protection by heparin in mouse brain bEND.3 endothelial cells.
Tsai TY; Leong IL; Cheng KS; Shiao LR; Su TH; Wong KL; Chan P; Leung YM
Fundam Clin Pharmacol; 2019 Feb; 33(1):52-62. PubMed ID: 29974515
[TBL] [Abstract][Full Text] [Related]
17. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.
Matsuda Y; Hirata K; Inoue N; Suematsu M; Kawashima S; Akita H; Yokoyama M
Circ Res; 1993 May; 72(5):1103-9. PubMed ID: 8477522
[TBL] [Abstract][Full Text] [Related]
18. Modulation of nonselective cation current by oxidized LDL and lysophosphatidylcholine and its inhibitory contribution to endothelial damage.
Liang GH; Park S; Kim MY; Kim JA; Choi S; Suh SH
Life Sci; 2010 May; 86(19-20):733-9. PubMed ID: 20226792
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells.
Lum H; Qiao J; Walter RJ; Huang F; Subbaiah PV; Kim KS; Holian O
Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1786-9. PubMed ID: 12805023
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidylcholine Promotes Phagosome Maturation and Regulates Inflammatory Mediator Production Through the Protein Kinase A-Phosphatidylinositol 3 Kinase-p38 Mitogen-Activated Protein Kinase Signaling Pathway During
Lee HJ; Ko HJ; Song DK; Jung YJ
Front Immunol; 2018; 9():920. PubMed ID: 29755479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
